121 related articles for article (PubMed ID: 9753066)
21. Acute myeloid leukaemia of mixed megakaryocytic and erythroid origin: a case report and review of the literature.
Daniëls L; Guerti K; Vermeulen K; De Raeve H; Van Assche E; Van de Velde AL; Berneman ZN; Van Der Planken M
Acta Clin Belg; 2007; 62(5):308-14. PubMed ID: 18229464
[TBL] [Abstract][Full Text] [Related]
22. Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.
Duensing S; Duensing A; Meran JG; Kreft A; Büsche G; Ganser A; Georgii A
Mol Pathol; 1999 Jun; 52(3):146-50. PubMed ID: 10621836
[TBL] [Abstract][Full Text] [Related]
23. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors.
Bobik R; Hong Y; Breier G; Martin JF; Erusalimsky JD
FEBS Lett; 1998 Feb; 423(1):10-4. PubMed ID: 9506832
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.
Campbell PK; Zong Y; Yang S; Zhou S; Rubnitz JE; Sorrentino BP
Leuk Res; 2011 Oct; 35(10):1321-9. PubMed ID: 21640380
[TBL] [Abstract][Full Text] [Related]
25. A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl.
Rouleau C; Cui K; Feldman L
Exp Hematol; 2004 Feb; 32(2):140-8. PubMed ID: 15102474
[TBL] [Abstract][Full Text] [Related]
26. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.
Wetzler M; Baer MR; Bernstein SH; Blumenson L; Stewart C; Barcos M; Mrózek K; Block AW; Herzig GP; Bloomfield CD
J Clin Oncol; 1997 Jun; 15(6):2262-8. PubMed ID: 9196139
[TBL] [Abstract][Full Text] [Related]
27. Glycoprotein 130 and c-kit signals synergistically induce thrombopoietin production by hematopoietic cells.
Matsui A; Sato T; Maekawa T; Asano S; Nakahata T; Tsuji K
Int J Hematol; 2000 Dec; 72(4):455-62. PubMed ID: 11197211
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development.
Basch RS; Zhang XM; Dolzhanskiy A; Karpatkin S
Br J Haematol; 1999 Jun; 105(4):1044-54. PubMed ID: 10554819
[TBL] [Abstract][Full Text] [Related]
29. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
30. Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blasts.
Wetzler M; Bernstein SH; Baumann H; Fries KM; Stewart C; Blumenson L; Baer MR; Herzig GP; Bloomfield CD; Slack JL
Leuk Lymphoma; 1998 Aug; 30(5-6):415-31. PubMed ID: 9711904
[TBL] [Abstract][Full Text] [Related]
31. MPLW515L mutation in acute megakaryoblastic leukaemia.
Hussein K; Bock O; Theophile K; Schulz-Bischof K; Porwit A; Schlue J; Jonigk D; Kreipe H
Leukemia; 2009 May; 23(5):852-5. PubMed ID: 19194467
[TBL] [Abstract][Full Text] [Related]
32. Lack of c-mpl proto-oncogene transcripts and growth-stimulatory effects of thrombopoietin on human small cell lung cancer cell lines.
Shinohara A; Shimizu E; Takada M; Sone S
Oncology; 1996; 53(5):426-34. PubMed ID: 8784480
[TBL] [Abstract][Full Text] [Related]
33. Thrombopoietin. A review.
Baatout S
Haemostasis; 1997; 27(1):1-8. PubMed ID: 9097080
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3.
Virchis A; Massey E; Butler T; Devaraj P; Wright F; Secker-Walker L; Prentice HG; Mehta A
Br J Haematol; 2001 Sep; 114(3):551-6. PubMed ID: 11552979
[TBL] [Abstract][Full Text] [Related]
35. Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT.
Ishiyama K; Yamaguchi T; Eto T; Ohashi K; Uchida N; Kanamori H; Fukuda T; Miyamura K; Inoue Y; Taguchi J; Mori T; Iwato K; Morishima Y; Nagamura-Inoue T; Atsuta Y; Sakamaki H; Takami A
Leuk Res; 2016 Aug; 47():47-53. PubMed ID: 27244257
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
37. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
[TBL] [Abstract][Full Text] [Related]
38. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features].
Takai K; Sanada M; Shibuya H
Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864
[TBL] [Abstract][Full Text] [Related]
39. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
Li J; Xia Y; Kuter DJ
Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
[TBL] [Abstract][Full Text] [Related]
40. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.
Souyri M
Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
